HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideki Nakamura Selected Research

prosultiamine

8/2013Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial.
1/2009Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideki Nakamura Research Topics

Disease

57Rheumatoid Arthritis
07/2022 - 04/2002
12Synovitis
07/2022 - 11/2007
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2010
8Inflammation (Inflammations)
03/2021 - 09/2011
7Fever (Fevers)
07/2022 - 09/2011
7Neoplasms (Cancer)
01/2022 - 05/2003
7Immunoglobulin G4-Related Disease
11/2021 - 10/2011
7Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
12/2017 - 06/2002
6Arthritis (Polyarthritis)
07/2022 - 06/2009
6Melanoma (Melanoma, Malignant)
03/2021 - 02/2004
6Vasculitis (Vasculitides)
11/2020 - 01/2006
6Dermatomyositis (Dermatopolymyositis)
03/2020 - 08/2006
6Infections
12/2019 - 01/2007
6Interstitial Lung Diseases (Interstitial Lung Disease)
06/2018 - 08/2006
6Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
01/2018 - 01/2009
6Edema (Dropsy)
01/2014 - 11/2007
5Fibrosis (Cirrhosis)
01/2022 - 11/2004
5Familial Mediterranean Fever (Periodic Disease)
09/2020 - 04/2016
5Autoimmune Diseases (Autoimmune Disease)
02/2020 - 03/2007
5Takayasu Arteritis (Arteritis, Takayasu's)
01/2019 - 01/2006
5Epidermolysis Bullosa
12/2017 - 01/2006
5Bullous Pemphigoid (Pemphigoid)
01/2016 - 03/2007
4Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2019 - 01/2006
4Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
08/2018 - 01/2015
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
08/2018 - 12/2007
4Muscular Dystrophies (Muscular Dystrophy)
04/2011 - 02/2005
3Giant Cell Arteritis (Horton Disease)
04/2022 - 01/2016
3Autonomic Nervous System Diseases (Dysautonomia)
01/2022 - 02/2020
3Rheumatic Diseases (Rheumatism)
11/2021 - 05/2019
3T-Cell Leukemia (Leukemia, T Cell)
09/2021 - 01/2018
3Lupus Nephritis
01/2021 - 04/2016
3Pain (Aches)
03/2020 - 08/2018
3Muscle Weakness
03/2020 - 10/2010
3Systemic Scleroderma (Systemic Sclerosis)
01/2020 - 07/2017
3Sepsis (Septicemia)
01/2020 - 01/2014
3Adult-Onset Still's Disease
01/2020 - 01/2014
3Arthralgia (Joint Pain)
12/2019 - 01/2015
3Tenosynovitis
10/2019 - 05/2013
3Skin Diseases (Skin Disease)
03/2019 - 06/2002
3Liver Cirrhosis (Hepatic Cirrhosis)
12/2018 - 11/2004
3Central Nervous System Lupus Vasculitis
01/2018 - 04/2015
3Blister (Bulla)
05/2015 - 02/2010
3Hemorrhage
01/2015 - 07/2007

Drug/Important Bio-Agent (IBA)

14Prednisolone (Predate)FDA LinkGeneric
04/2022 - 01/2006
13Biomarkers (Surrogate Marker)IBA
07/2021 - 05/2011
13Biological ProductsIBA
01/2021 - 01/2010
13AntibodiesIBA
02/2020 - 07/2002
12tocilizumab (atlizumab)FDA Link
04/2022 - 02/2010
12Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 12/2007
12AutoantibodiesIBA
02/2020 - 12/2007
11Immunoglobulin G (IgG)IBA
07/2022 - 02/2010
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2021 - 01/2002
11CytokinesIBA
04/2020 - 07/2002
10Tumor Necrosis Factor InhibitorsIBA
09/2021 - 02/2010
10Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2020 - 07/2007
10Adrenal Cortex Hormones (Corticosteroids)IBA
12/2018 - 08/2006
9Antirheumatic Agents (DMARD)IBA
01/2021 - 04/2012
8Abatacept (Orencia)FDA Link
02/2022 - 05/2013
8EnzymesIBA
01/2020 - 04/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 04/2004
8Anti-Citrullinated Protein AntibodiesIBA
12/2019 - 01/2006
8Pharmaceutical PreparationsIBA
05/2019 - 05/2003
7DNA (Deoxyribonucleic Acid)IBA
07/2022 - 12/2004
7Rheumatoid FactorIBA
12/2019 - 01/2006
7Collagen Type XVIIIBA
12/2017 - 03/2007
6Adalimumab (Humira)FDA Link
12/2019 - 09/2011
6Tacrolimus (Prograf)FDA LinkGeneric
11/2019 - 07/2007
6C-Reactive ProteinIBA
10/2019 - 11/2007
6Immunoglobulin M (IgM)IBA
03/2013 - 01/2006
5Infliximab (Remicade)FDA Link
12/2018 - 01/2006
5Interleukin-6 (Interleukin 6)IBA
10/2018 - 11/2007
5MethylprednisoloneFDA LinkGeneric
06/2018 - 01/2006
5PlectinIBA
12/2017 - 02/2005
4SteroidsIBA
08/2022 - 01/2006
4AntigensIBA
07/2022 - 08/2002
4GadoliniumIBA
01/2022 - 06/2009
4cyclic citrullinated peptideIBA
03/2021 - 01/2006
4Methotrexate (Mexate)FDA LinkGeneric
11/2019 - 01/2006
4ColchicineFDA LinkGeneric
10/2019 - 09/2018
4GlucocorticoidsIBA
05/2019 - 01/2006
4Ferritins (Ferritin)IBA
03/2019 - 01/2015
4Complement System Proteins (Complement)IBA
08/2018 - 11/2014
4Peroxidase (Myeloperoxidase)IBA
02/2018 - 07/2007
4Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2004
4Etanercept (Enbrel)FDA Link
06/2011 - 01/2009
3Messenger RNA (mRNA)IBA
07/2022 - 07/2002
3Therapeutic UsesIBA
01/2022 - 07/2016
3Rituximab (Mabthera)FDA Link
01/2022 - 06/2018
3tofacitinibIBA
01/2021 - 12/2016
3InterleukinsIBA
01/2020 - 01/2014
3ImmunosorbentsIBA
01/2020 - 05/2003
3InterferonsIBA
09/2017 - 06/2014
3EpitopesIBA
01/2016 - 02/2010
3Immunoglobulins (Immunoglobulin)IBA
01/2016 - 10/2010
3Anti-Bacterial Agents (Antibiotics)IBA
02/2015 - 11/2014
3mizoribineIBA
11/2014 - 01/2010
3Keratin-5 (Keratin 5)IBA
09/2013 - 06/2002
3Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2010 - 08/2006

Therapy/Procedure

44Therapeutics
08/2022 - 04/2002
3Drug Therapy (Chemotherapy)
07/2022 - 02/2004